Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.63 |
| ▸ | CNR2 | P34972 | 6/20 | 0.62 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.62 |
| ▸ | CNR1 | P21554 | 3/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.58 |
| ▸ | MLNR | O43193 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | PDE9A | O76083 | 1/20 | 0.58 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.58 |
| ▸ | LDHA | P00338 | 1/20 | 0.58 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23765310 | 0.83 | BCHE (0.42) | BCHECNR2OPRM1CNR1 | |
| SCHEMBL23160876 | 0.82 | BCHE (0.80) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL19472310 | 0.82 | BCHE (0.80) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL22848084 | 0.80 | BCHE (0.77) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL22848082 | 0.80 | BCHE (0.77) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL31546095 | 0.80 | CNR2 (0.74) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL20181621 | 0.80 | CNR2 (0.74) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL22848036 | 0.80 | BCHE (0.95) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL25560685 | 0.80 | OPRM1 (0.82) | BCHECNR2OPRM1CNR1TRPV1 | |
| SCHEMBL3646527 | 0.80 | BCHE (0.76) | BCHECNR2OPRM1CNR1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| WO-2021163023-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. (US) | 2021-08-19 | — | — | WO | disclosed |
| US-20210251947-A1 | STABLE FORMULATIONS OF DRONABINOL | TRYAGx Labs Inc. | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210251947-A1 | STABLE FORMULATIONS OF DRONABINOL | CNR2, CNR1, GPR18 | BCHE 1928/4885CNR2 1/4885OPRM1 9/4885 |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | SLC25A20, CPT2, NDUFAB1 | BCHE 874/4885CNR2 91/4885OPRM1 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.